Concepedia

Jos van der Velden

JV

43

Publications

2.6K

Citations

30

H-Index

1999

Active since

Affiliations

University of Vermont(Current)

Maastricht University

Maastricht University Medical Centre

University of Vermont Medical Center

Ludwig Boltzmann Institute for Lung Vascular Research

Jos van der Velden is an author at University of Vermont specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1999–2023

43

Publications

43

Tumor necrosis factor‐alpha inhibits myogenic differentiation through MyoD protein destabilization

Ramon Langen, Jos van der Velden, Annemie M.W.J. Schols et al. · The FASEB Journal · 2004 · 318 citations

, , +18

Muscle Wasting and Impaired Muscle Regeneration in a Murine Model of Chronic Pulmonary Inflammation

Ramon Langen, Annemie M.W.J. Schols, Marco Kelders et al. · American Journal of Respiratory Cell and Molecular Biology · 2006 · 136 citations

, , +15

Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways

Ramon Langen, Annemie M.W.J. Schols, Marco Kelders et al. · American Journal of Physiology-Cell Physiology · 2002 · 132 citations

Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1

John F. Alcorn, Amy S. Guala, Jos van der Velden et al. · Journal of Cell Science · 2008 · 124 citations · Full text

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

Jos van der Velden, Ying Ye, James D. Nolin et al. · Clinical and Translational Medicine · 2016 · 118 citations · Full text

Rows per page

1–5 of 43